In the orthotopic tumor implantation model (depicted in Figure 1C), we first titrated the combination of Gem plus Ptx to find the ideal dose that would allow us to assess the combination plus the PRMT5 inhibitor (PRMT5i) (Supplemental Figure S1). This evidence concerns the gene PRMT5 and neoplasm.